Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pharvaris N.V. - Ordinary Shares (NQ: PHVS )

17.53 +0.36 (+2.10%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pharvaris N.V. - Ordinary Shares

< Previous 1 2 3 4 5 Next >
Dow Tumbles 150 Points; Crude Oil Falls Sharply
U.S. stocks turned lower midway through trading, with the Dow Jones dropping around 150 points on Wednesday. 
Via Benzinga
Gorilla Technology And Some Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded lower, with the Dow Jones dropping around 40 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
BlackBerry, Calavo Growers And Some Other Big Stocks Moving Lower On Wednesday
U.S. stocks traded higher, with the Dow Jones gaining over 500 points on Wednesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Major Indexes Struggle For Direction After Inflation Report
The major indexes are trying to claw back from this morning's fall, prompted by a higher-than-anticipated producer price index (PPI) for November. 
Via Talk Markets
Why Pharvaris Shares Are Plummeting Today?
Via Benzinga
Why Ambrx Biopharma Shares Are Trading Higher By Over 550%? Here Are 52 Stocks Moving In Friday's Mid-Day Session
Gainers Ambrx Biopharma Inc. (NYSE: AMAM) shares jumped 551.4% to $2.67 after the company announced preliminary Phase 2 results from its ACE-Breast-03 study showing a 57.1% overall response rate. 
Via Benzinga
Lululemon, Li Auto, Hackett Group And Some Other Big Stocks Moving Lower On Friday
U.S. stocks traded lower, with the Dow Jones jumping around 70 points on Friday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Why Autolus Therapeutics Shares Are Trading Lower By Around 26%; Here Are 28 Stocks Moving Premarket
Gainers Baudax Bio, Inc. (NASDAQ: BXRX) shares rose 48.2% to $6.03 in pre-market trading after jumping over 20% on Thursday. Baudax Bio initiated Phase II clinical trial evaluating BX1000 in patients... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
The trading week is almost complete but we've still got the biggest pre-market stock movers to go over for Friday morning! 
Via InvestorPlace
Tesla, Amazon, Costco, Pharvaris, Lululemon: Why These 5 Stocks Are Drawing Investors' Attention Today
Major Wall Street indices closed in the green on Thursday after investors and traders questioned the possibility of continued aggression by the Federal Reserve following the release of joble 
Via Benzinga
S&P 500 Rises 0.5%; Ciena Posts Upbeat Q4 Results
U.S. stocks traded higher toward the end of trading, with the NASDAQ gaining around 100 points on Thursday. 
Via Benzinga
Pharvaris Shares Surges On Positive Data From HAE Attacks Study, Makes Way For FDA To Remove Clinical Hold
Via Benzinga
Why Express Shares Are Trading Higher By 39%? Here Are 50 Stocks Moving In Thursday's Mid-Day Session
Gainers My Size, Inc. (NASDAQ: MYSZ) shares jumped 88% to $0.2839. My Size announced a 1-for-25 reverse stock split. 
Via Benzinga
Nasdaq Gains 100 Points; Rent the Runway Shares Spike Higher
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 100 points on Thursday. 
Via Benzinga
Transocean (RIG) Stock Jumps on New Contract Awards
Transocean (RIG) stock is rising on Thursday after announcing $1.04 billion in new contract awards from a national oil company. 
Via InvestorPlace
Why Is Pharvaris (PHVS) Stock Up 62% Today?
Pharvaris (PHVS) stock is heading higher on Thursday following the release of positive results from a Phase 2 clinical study. 
Via InvestorPlace
Dow Rises 150 Points; US Jobless Claims Increase To 230,000
U.S. stocks traded higher this morning, with the Dow Jones gaining over 150 points on Thursday. 
Via Benzinga
Pharvaris Reports Third Quarter 2022 Financial Results and Provides Business Update
From Pharvaris N.V.
Via GlobeNewswire
Pharvaris Announces Positive Top-line Phase 2 Data from RAPIDe-1 Study of PHVS416 for the On-Demand Treatment of HAE Attacks
From Pharvaris N.V.
Via GlobeNewswire
Pharvaris to Present PHVS416 and PHVS719 Clinical Data for Treatment of HAE at the ACAAI Annual Scientific Meeting 2022
From Pharvaris N.V.
Via GlobeNewswire
Pharvaris Presents Data Supporting HAE Drug Development Strategy at the 2022 HAEi Global Leadership Workshop
From Pharvaris N.V.
Via GlobeNewswire
Why Oil-Related Stocks Traded Higher; Here Are 74 Biggest Movers From Yesterday
Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) shares surged 637.6% to close at $2.01 on Monday after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per... 
Via Benzinga
Pharvaris Announces the Promotion of Annick Deschoolmeester to Chief Human Resources Officer
From Pharvaris N.V.
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Friday
  During Friday's session, 132 stocks hit new 52-week lows. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 23, 2022
  
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 63 companies set new 52-week lows. 
Via Benzinga
AMC Entertainment Price Target Cut By This Analyst, Plus DA Davidson Predicts $318 For Estée Lauder
DA Davidson cut the price target for The Estée Lauder Companies Inc. (NYSE: EL) from $342 to $318. Estée Lauder shares fell 0.4% to $264.29 in pre-market trading. 
Via Benzinga
Why Amazon Shares Traded Lower; Here Are 74 Biggest Movers From Yesterday
Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 72.8% to close at $2.16 on Monday as the stock continued to see momentum despite the company last week announcing it is not aware of... 
Via Benzinga
Why MSP Recovery Is Trading Higher By Over 21%, Here Are 61 Stocks Moving In Monday's Mid-Day Session
 Losers 
Via Benzinga
Why Pharvaris Stock Crashed — And Why At Least One Analyst Isn't Worried
Shares hit their lowest point since November on the FDA's decision in HAE. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.